estrogen therapy

Naturally produced estrogen may protect women from Parkinson's disease

harminka — Thu, 26 Feb 2009 02:03:29 -0600

Women who have more years of fertility (the time from first menstruation to menopause) have a lower risk of developing Parkinson’s disease than women with fewer years, according to a large, new study by researchers at Albert Einstein College of Medicine of Yeshiva University.

Estrogen pills can benefit women with metastatic breast cancer

harminka — Fri, 12 Dec 2008 15:26:49 -0600

For breast cancer survivors, the idea of taking estrogen pills is almost a taboo. In fact, their doctors give them drugs to get rid of the hormone because it can fuel the growth of breast cancer.

Improved estrogen reception may sharpen fuzzy memory

harminka — Thu, 31 Jul 2008 00:27:33 -0500

Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.

Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women

harminka — Wed, 11 Jun 2008 01:03:11 -0500

New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers.

Doctors can unmask deceptive high-risk breast tumors

harminka — Thu, 22 May 2008 01:02:39 -0500

A unique genetic signature can alert physicians to high-risk breast tumors that are masquerading as low-risk tumors, according to research at Washington University School of Medicine in St. Louis and collaborating institutions. Although these tumors are apparently estrogen-receptor positive — meaning they should depend on estrogen to grow — they don't respond well to anti-estrogen therapy.

Adverse effects of estrogen replacement therapy are related to dose

harminka — Mon, 07 Apr 2008 12:57:42 -0500

Recent clinical trials indicate that estrogen replacement therapy (ERT) may increase the risk of cardiovascular diseases. A new study in mice has examined whether adverse effects of ERT are related to the doses used

High levels of estrogen associated with breast cancer recurrence

harminka — Thu, 06 Mar 2008 01:18:02 -0600

Women whose breast cancer came back after treatment had almost twice as much estrogen in their blood than did women who remained cancer-free – despite treatment with anti-estrogen drugs in a majority of the women –according to researchers in a study published in the March issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

Health risks after cessation of postmenopausal hormone therapy

harminka — Wed, 05 Mar 2008 12:41:10 -0600

The Women’s Health Initiative (WHI) investigators have produced another article [1], which probably marks the opening of another set of publications, in which the consequences of a further 2.4-year follow-up (after cessation of the study medication) on the estrogen + progestogen (E + P) cohort are reported.

Follow-up to women's health initiative produces surprising results

harminka — Wed, 05 Mar 2008 05:33:58 -0600

An increased cancer risk in post-menopausal women after they stopped taking combined hormone therapy was an “unexpected finding” in a study that will be reported in the March 5 edition of the Journal of the American Medical Association (JAMA), said Rowan T. Chlebowski, M.D., Ph.D., a Los Angeles Biomedical Research Institute (LA BioMed) lead investigator who contributed to the study.

Stopping estrogen plus progestin therapy may increase risk of cancer

harminka — Wed, 05 Mar 2008 02:32:04 -0600

A follow-up study of women who stopped taking the hormone therapy of estrogen plus progestin after this intervention was discontinued as part of a clinical trial indicates that these women may have an increased risk of cancer, compared to women in the placebo group, according to a study in the March 5 issue of JAMA.

Estrogen protects women's brains prior to menopause

harminka — Thu, 30 Aug 2007 02:23:21 -0500

In the largest study of its kind, Mayo Clinic researchers have shown that women who had one or both ovaries removed before menopause faced an increased long-term risk of cognitive impairment or dementia, compared to women who retained their ovaries.

Flaxseed shows potential to reduce hot flashes

harminka — Thu, 30 Aug 2007 02:13:59 -0500

Data from a new Mayo Clinic (http://mayoclinic.edu) study suggest that dietary therapy using flaxseed can decrease hot flashes in postmenopausal women who do not take estrogen. The findings from the pilot study are published in the summer 2007 issue of the Journal of the Society for Integrative Oncology.